DETECTION OF INDUCIBLE CLINDAMYCIN RESISTANCE AMONG COAGULASE NEGATIVE STAPHYLOCOCCUS ISOLATED FROM HEALTHY POPULATION

Authors

  • Deeksheeta P Undergraduate Student, Department of Prosthodontics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical And Technical Sciences, Saveetha University, Chennai, India. Author
  • Gopinath Assistant Professor, Department of Microbiology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical And Technical Sciences, Chennai – 600077 Tamil Nadu, India Author
  • Dhanraj Ganapathy Professor and Head Department of Prosthodontics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical And Technical Sciences, Chennai – 600077 Tamil Nadu, India Author

DOI:

https://doi.org/10.61841/72m9mk77

Keywords:

Coagulase-negative staphylococci (CoNS), inducible clindamycin resistance

Abstract

Clindamycin is an attractive agent for empirical therapy for various infections because of its excellent pharmacokinetic and pharmacodynamic properties. Clinical failures of clindamycin therapy for treatment of MRSA infections have been documented for strains that were clindamycin sensitive but erythromycin resistant. The failures were due to inducible resistance to clindamycin. A total of 20 normal flora isolates of Coagulase-negative staphylococci (CoNS) were subjected to an antibiotic sensitivity pattern followed by an inducible clindamycin resistance test. 20% were found to be D test-positive strains. The D-test is a simple & reliable method to detect inducible & constitutive clindamycin resistance in routine clinical diagnosis settings. 

Downloads

Download data is not yet available.

References

1. Lyall KDS, Gupta V, Chhina D. 2013. Inducible clindamycin resistance among clinical isolates of Staphylococcus aureus. Journal of the Mahatma Gandhi Institute of Medical Sciences. 18(2). 112-115.

2. Ghosh S, Banerjee M. 2016. Methicillin resistance & inducible clindamycin resistance in Staphylococcus aureus. Indian J Med Res. 143 (3). 362-364.

3. Roberts MC, Sutcliffe J, Courvalin P, Jensen LB, Rood J, Seppala H. 1999. Nomenclature for macrolide and macrolide-lincosamide streptogramin B resistance determinants. Antimicrob Agents Chemother. 43:2823-30.

4. Fiebelkorn KR, Crawford SA, McElmeel ML, Jorgensen JH. 2003. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol. 41:4740-4.

5. Clinical and laboratory standards institute. Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement. Clinical Laboratory Standards Institute. 2015; Vol. 2(No. 1).

6. Kloos WE, Banerman TL. 1999. Staphylococcus and Micrococcus. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Chapter 22. Manual of clinical microbiology. Washington DC: ASM Press. 264–82.

7. Watanakunakorn C. 1976. Clindamycin therapy of Staphylococcus aureus endocarditis: clinical relapse and development of resistance to clindamycin, lincomycin, and erythromycin. Am J Med. 60:419-25.

8. Drinkovic D, Fuller ER, Shore KP, Holland DJ, Ellis-Pegler R. 2001. Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance. J Antimicrob Chemother. 48:315-6.

9. Siberry GK, Tekle T, Carroll K, Dick J. 2003. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis.37:1257-60.

Downloads

Published

30.04.2020

Issue

Vol. 24 No. 2 (2020): 24 (2) 2020

Section

Articles

License

Copyright (c) 2020 AUTHOR

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  1. Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
  2. Adapt — remix, transform, and build upon the material for any purpose, even commercially.
  3. The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  1. Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  2. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Notices:

You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .

No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.

How to Cite

P, D., Gopinath, & Ganapathy, D. (2020). DETECTION OF INDUCIBLE CLINDAMYCIN RESISTANCE AMONG COAGULASE NEGATIVE STAPHYLOCOCCUS ISOLATED FROM HEALTHY POPULATION. International Journal of Psychosocial Rehabilitation, 24(2), 7481-7487. https://doi.org/10.61841/72m9mk77